Plasmids were linearized by restriction digestion with PvuI (NEB) before transfection. HAC donor CHO cells (8 × 104/well in 24-well plates (Nunc)) were co-transfected with 0.3 μg each of pTNH6-H and pCAG-T7-F, and 0.25 μg of pDsRed-Monomer-N1 (Clontech) using Lipofectamine 2000 (Invitrogen). At 24 h after transfection, the cells were re-plated at low density and selected for 14 days with 800 μg/ml of G418 (Nacalai). Drug-resistant cells were recovered as a mixed population. HT1080 cells (2 × 106/6 cm dish) were co-transfected with 0.4 μg each of pTNH6-H and pCAG-T7-F. After culture for 6 h, syncytium formation was tested under the microscope.
Generation of scFv-expressing Vectors
Plasmids were linearized by restriction digestion with PvuI (NEB) before transfection. HAC donor CHO cells (8 × 104/well in 24-well plates (Nunc)) were co-transfected with 0.3 μg each of pTNH6-H and pCAG-T7-F, and 0.25 μg of pDsRed-Monomer-N1 (Clontech) using Lipofectamine 2000 (Invitrogen). At 24 h after transfection, the cells were re-plated at low density and selected for 14 days with 800 μg/ml of G418 (Nacalai). Drug-resistant cells were recovered as a mixed population. HT1080 cells (2 × 106/6 cm dish) were co-transfected with 0.4 μg each of pTNH6-H and pCAG-T7-F. After culture for 6 h, syncytium formation was tested under the microscope.
Corresponding Organization : Japan Science and Technology Agency
Other organizations : Tottori University, Fujita Health University
Variable analysis
- PCR amplification of scFv-encoding DNA sequence using scFv-expressing vector clones as template
- Insertion of BsiWI-fragment of pCAG-T7F into pVITRO1-neo-mcs to create pVF#9
- Insertion of BsrGI-fragment of pTNH6-HaalsαTfR-#5 into the BsrGI site of pVF#9 to create pVF#9-TfR
- Linearization of plasmids by restriction digestion with PvuI before transfection
- Co-transfection of HAC donor CHO cells with pTNH6-H, pCAG-T7-F, and pDsRed-Monomer-N1
- Co-transfection of HT1080 cells with pTNH6-H and pCAG-T7-F
- Outcome of syncytium formation in HT1080 cells
- Use of Lipofectamine 2000 for transfection of HAC donor CHO cells
- Selection of drug-resistant HAC donor CHO cells with 800 μg/ml of G418 for 14 days
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!